{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:22:10Z","timestamp":1778070130274,"version":"3.51.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,13]]},"abstract":"<jats:p>\n                    Platelet transfusion is commonly utilized in the surgical intensive care unit (ICU) to provide hemostatic support for patients with severe thrombocytopenia or bleeding. Ineffective platelet transfusion is described as either the expected platelet count increase or insufficient hemostasis following transfusion. This study sought to identify risk factors and assess their predictive value in improving patient outcomes. This was an observational, retrospective study. Clinical information was gathered from 302 platelet transfusion episodes that occurred in the surgical ICU at the First Affiliated Hospital of Sun Yat-sen University, between June and December 2022. Based on the clinical bleeding improvement indices (drainage volume, hemoglobin level) and the 24 hour-corrected count increment, the patients were divided into effective and ineffective groups. Binomial logistic regression was used to identify independent risk factors for ineffective transfusion after univariate analysis was screened for significant variables (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). The predictive performance of these factors was assessed using receiver operating characteristic (ROC) curves. Patients were separated into 2 groups: effective (n\u2005=\u2005192) and ineffective (n\u2005=\u2005110). Baseline comparisons demonstrated significant differences in surgery frequency (\u22641 vs &gt;1), liver disease, intraoperative bleeding (\u22641600 vs &gt;1600), procalcitonin (PCT) level, C-reactive protein level, splenomegaly, and age (\u226565 vs &lt;65 years) (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). The total red blood cell transfusion volume and other indicators showed no intergroup differences (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). Univariate logistic regression revealed a significant association (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05) between platelet transfusion refractoriness and these variables, including the total red blood cell transfusion volume. Multivariate logistic regression analysis identified surgeries (&gt;1) (odds ratio (OR)\u2005=\u20051.997, 95% confidence interval (CI): 1.196\u20133.335;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.008), splenomegaly (OR\u2005=\u20053.912, 95% CI: 2.277\u20136.720;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), and PCT (OR\u2005=\u20051.030, 95% CI: 1.013\u20131.047;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) as independent risk variables (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). ROC curve analysis revealed that the area under the curve of the model was 0.706 (95% CI: 0.645\u20130.766), with a Youden index of 0.346, corresponding to an optimal cutoff value of 0.338, sensitivity of 66.40%, and specificity of 68.20%. The number of surgeries (&gt;1), splenomegaly, and PCT level were independent risk factors for ineffective platelet transfusion, and the constructed model had moderate predictive efficacy, providing a reference for early clinical identification and intervention.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048062","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:01:07Z","timestamp":1773432067000},"page":"e48062","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of ineffective platelet transfusion in surgical ICU: A retrospective study"],"prefix":"10.1097","volume":"105","author":[{"given":"Jin Fang","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Blood Transfusion, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen Hai","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260506","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/aas.14467","article-title":"Platelet transfusions in adult ICU patients with thrombocytopenia: a sub-study of the PLOT-ICU inception cohort study.","volume":"68","author":"Anthon","year":"2024","journal-title":"Acta Anaesthesiol Scand"},{"key":"R2-20260506","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/bjh.14572","article-title":"24-h continuous infusion of platelets for patients with platelet transfusion refractoriness.","volume":"181","author":"Cid","year":"2018","journal-title":"Br J Haematol"},{"key":"R3-20260506","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.chest.2016.04.004","article-title":"Platelet transfusion practices in the ICU: data from a large transfusion registry.","volume":"150","author":"Ning","year":"2016","journal-title":"Chest"},{"key":"R4-20260506","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1537-2995.2006.00892.x","article-title":"Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.","volume":"46","author":"Arnold","year":"2006","journal-title":"Transfusion"},{"key":"R5-20260506","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s12185-023-03557-3","article-title":"A meta-analysis of risk factors associated with platelet transfusion refractoriness.","volume":"117","author":"Song","year":"2023","journal-title":"Int J Hematol"},{"key":"R6-20260506","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5045\/br.2022.2021229","article-title":"Evaluation and management of platelet transfusion refractoriness.","volume":"57","author":"Youk","year":"2022","journal-title":"Blood Res"},{"key":"R7-20260506","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1272\/jnms.JNMS.2023_90-104","article-title":"The role of the spleen in portal hypertension.","volume":"90","author":"Yoshida","year":"2023","journal-title":"J Nippon Med Sch"},{"key":"R8-20260506","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1055\/s-0040-1708827","article-title":"A champion of host defense: a generic large-scale cause for platelet dysfunction and depletion in infection.","volume":"46","author":"Page","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"R9-20260506","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood.2023022883","article-title":"How I treat patients who are refractory to platelet transfusions.","volume":"145","author":"Nahirniak","year":"2025","journal-title":"Blood"},{"key":"R10-20260506","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/17511437231206013","article-title":"Prophylactic platelet transfusions in critical care: How low can you go?","volume":"25","author":"Shah","year":"2024","journal-title":"J Intensive Care Soc"},{"key":"R11-20260506","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/sim.9275","article-title":"Minimum sample size calculations for external validation of a clinical prediction model with a time-to-event outcome.","volume":"41","author":"Riley","year":"2022","journal-title":"Stat Med"},{"key":"R12-20260506","first-page":"2198","article-title":"Analysis of efficacy of platelet transfusion in 469 case (translated from Chinese).","volume":"37","author":"Jingjing","year":"2016","journal-title":"Int J Laboratory Med"},{"key":"R13-20260506","first-page":"897","article-title":"Chinese expert consensus on the diagnosis and management of platelet transfusion refractoriness (2022).","volume":"43","year":"2022","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"R14-20260506","first-page":"2554","article-title":"Clinical efficacy of platelet transfusion therapy in patients with leukemia and analysis of risk factors for ineffective transfusion.","volume":"19","author":"Chen","year":"2020","journal-title":"Oncol Lett"},{"key":"R15-20260506","first-page":"e46161","article-title":"Factors influencing corrected count increment after platelet transfusion in thrombocytopenic patients.","volume":"15","author":"Prasad Sahu","year":"2023","journal-title":"Cureus"},{"key":"R16-20260506","doi-asserted-by":"crossref","first-page":"27966","DOI":"10.1038\/srep27966","article-title":"Body surface area formulae: an alarming ambiguity.","volume":"6","author":"Redlarski","year":"2016","journal-title":"Sci Rep"},{"key":"R17-20260506","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00134-023-07303-5","article-title":"Contemporary management of major haemorrhage in critical care.","volume":"50","author":"Maier","year":"2024","journal-title":"Intensive Care Med"},{"key":"R18-20260506","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1537-2995.2004.03231.x","article-title":"Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers.","volume":"44","author":"Cook","year":"2004","journal-title":"Transfusion"},{"key":"R19-20260506","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.","volume":"8","author":"Schulman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R20-20260506","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.2025.7529","article-title":"Platelet transfusion: 2025 AABB and ICTMG international clinical practice guidelines.","volume":"334","author":"Metcalf","year":"2025","journal-title":"JAMA"},{"key":"R21-20260506","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/trf.15670","article-title":"Bleeding assessment and bleeding severity in thrombocytopenic patients undergoing invasive procedures.","volume":"60","author":"van Baarle Frank","year":"2020","journal-title":"Transfusion"},{"key":"R22-20260506","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13054-022-03928-y","article-title":"Impact of platelet transfusion on outcomes in trauma patients.","volume":"26","author":"Hamada","year":"2022","journal-title":"Crit Care"},{"key":"R23-20260506","doi-asserted-by":"crossref","first-page":"2229905","DOI":"10.1080\/09537104.2023.2229905","article-title":"Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases.","volume":"34","author":"Song","year":"2023","journal-title":"Platelets"},{"key":"R24-20260506","first-page":"5589768","article-title":"Prevalence, risk factors, and outcomes of platelet transfusion refractoriness in critically ill patients: a retrospective cohort study.","volume":"2021","author":"Arabi","year":"2021","journal-title":"Crit Care Res Pract"},{"key":"R25-20260506","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000543635","article-title":"Procalcitonin as an early predictive marker for infectious complications after hepatectomy.","volume":"42","author":"Mori","year":"2025","journal-title":"Dig Surg"},{"key":"R26-20260506","doi-asserted-by":"crossref","first-page":"1632042","DOI":"10.3389\/fmed.2025.1632042","article-title":"Analysis of influencing factors and predictive model construction for platelet transfusion efficacy in hematological patients.","volume":"12","author":"Zou","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"R27-20260506","doi-asserted-by":"crossref","first-page":"e26555","DOI":"10.1097\/MD.0000000000026555","article-title":"Prognostic values of procalcitonin and platelet in the patient with urosepsis.","volume":"100","author":"Jiang","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"R28-20260506","first-page":"69","article-title":"Splenomegaly and hypersplenism in hepatic vena cava syndrome.","volume":"2","author":"Man Shrestha","year":"2021","journal-title":"Hepatol Forum"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:07:02Z","timestamp":1778069222000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048062","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"2025-10-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}